No Data
No Data
Express News | 111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility
Earnings Call Summary | 111 Inc(YI.US) Q1 2024 Earnings Conference
The following is a summary of the 111, Inc. (YI) Q1 2024 Earnings Call Transcript:Financial Performance:111 Inc achieved operational profitability in the first quarter of 2024 for the first time.The c
111 Inc | 6-K: Report of foreign private issuer (related to financial reporting)
111 Q1 Adj EPADS $(0.02), Same YoY, Sales $488.68M Down From $538.29M YoY
111 (NASDAQ:YI) reported quarterly Adj Loss per ADS of $(0.02). This is unchanged from the same period last year. The company reported $488.68 million in sales this quarter. This is a 9.22 percent dec
YI.US (YI.US) achieved full profit at the operating level in a single quarter with revenue of 3.53 billion yuan for the first time in a single quarter
On May 23, YI.US (YI.US) released the first quarter results report of 2024. According to the report, 1Pharmaceutical Network achieved revenue of 3.53 billion yuan in the quarter; non-GAAP operating profit was 8.9 million yuan. At the same time, GAAP operating profit was corrected for the first time in a single quarter. GAAP operating profit reached 3.72 million yuan, and positive operating cash flow was achieved, thus marking an important milestone in 1Pharma Network's phased profit. The positive results for this quarter are related to the long-term steady growth and continuous strategic operation optimization and efficiency improvement of 1 Pharmaceutical Network. During the reporting period, 1 Pharmaceutical Network managed and managed the company
111 Inc. CEO: See Possibility for Further Operating Cost Reductions, Higher Efficiency as Company Scales Up >YI
111 Inc. CEO: See Possibility for Further Operating Cost Reductions, Higher Efficiency as Company Scales Up >YI
No Data